|Articles|May 6, 2003
Robotically implanted, bioengineered microfistula shows promise as innovation for glaucoma drainage surgery
Ft. Lauderdale-Robotic biological microfistula implantation appears to be a reliable and controllable way to produce a scleral channel between the anterior chamber and subconjunctival space based on animal trials.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Study identifies 6 key genes linking air pollution to dry eye disease
2
Nanoscope Therapeutics releases positive long-term safety results from EXTEND study
3
Q&A: Karolinne M. Rocha discusses the IOL and patient tolerance of residual astigmatism
4
Avisi Technologies releases positive 12-month data from VITA Trial
5














































.png)


